GSK-3/CDK5/CDK2-IN-1

GSK-3/CDK5/CDK2-IN-1

• CAS Number: 395074-72-3
• UNSPSC Description: GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer, and neurodegenerative diseases[1].
• Target Antigen: CDK; GSK-3
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Stem Cell/Wnt
• Field of Research: Cancer; Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/gsk-3-cdk5-cdk2-in-1.html
• Smiles: O=C(NC1=CN([C@H]2C[C@@H](NC(C)=O)C2)C=N1)CC3=CC=C4C=CC=CC4=C3
• Molecular Weight: 362.42
• References & Citations: [1]Ahlijanian MK, et, al. Preparation of acylaminoimidazoles as inhibitors of cdk5, cdk2, and GSK-3. WO2002010141A1.
• Shipping Conditions: Room Temperature